RHUMBLINE ADVISERS - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 74 filers reported holding CYTOSORBENTS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q2 2023$6,810
-94.7%
1,897
-95.3%
0.00%
Q1 2022$128,000
-23.8%
40,176
-0.0%
0.00%
Q4 2021$168,000
-49.4%
40,192
-1.6%
0.00%
Q3 2021$332,000
+8.9%
40,852
+1.1%
0.00%
Q2 2021$305,000
-17.3%
40,427
-5.0%
0.00%
-100.0%
Q1 2021$369,000
+3.1%
42,558
-5.3%
0.00%
Q4 2020$358,000
+11.9%
44,923
+11.8%
0.00%
-100.0%
Q3 2020$320,000
-26.9%
40,171
-9.1%
0.00%0.0%
Q2 2020$438,000
+46.5%
44,211
+14.1%
0.00%0.0%
Q1 2020$299,000
+100.7%
38,7340.0%0.00%
Q4 2019$149,000
-23.2%
38,734
+0.5%
0.00%
Q3 2019$194,000
-24.5%
38,527
-0.8%
0.00%
Q2 2019$257,000
-20.2%
38,827
-8.8%
0.00%
-100.0%
Q1 2019$322,000
+4.5%
42,589
+11.7%
0.00%0.0%
Q4 2018$308,000
-3.1%
38,135
+54.8%
0.00%0.0%
Q3 2018$318,000
+7.8%
24,630
-4.8%
0.00%0.0%
Q2 2018$295,00025,8810.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 964,141$7,829,0001.90%
Skylands Capital, LLC 1,837,541$14,921,0001.84%
CM Management, LLC 175,000$1,421,0001.06%
Soleus Capital Management, L.P. 800,000$6,496,0001.01%
Avenir Corp 1,395,385$11,331,0000.95%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,502,0000.55%
Winning Points Advisors, LLC 86,200$701,0000.51%
Granahan Investment Management 1,154,561$9,375,0000.18%
SECTORAL ASSET MANAGEMENT INC 244,660$1,987,0000.16%
Redmile Group, LLC 1,044,434$8,481,0000.15%
View complete list of CYTOSORBENTS CORP shareholders